Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00042445 · ClinicalTrials.gov registry record
Brain Neoplasms, Leukemia and Petrochemical Exposures
A clinical trial, sponsored by National Institute of Environmental Health Sciences (NIEHS).
- Completed
- Registry status
- 1,456
- Enrollment target
NCT00042445: Completed study, sponsored by National Institute of Environmental Health Sciences (NIEHS).
NCT00042445 is a clinical trial that has completed, run by National Institute of Environmental Health Sciences (NIEHS). The registered enrollment target is 1,456 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00042445 has completed, sponsored by National Institute of Environmental Health Sciences (NIEHS).
- COMPLETED
- Registry status
- 1,456 participants
- Enrollment target
Study Summary
The aim of this study is to examine the association of exposure to air contaminants (PAH \& VOC) emitted from the petrochemical industries, specific genetic polymorphisms (P4501A1 (MspI \& exon 7) and GSTM1 \& T1) of study subjects and their parents, and the risks of brain tumors and leukemia among children and youths in metropolitan Kaohsiung, southern Taiwan.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1,456 participants |
| Start Date | 2000-08 |
| Est. Completion | 2005-07 |
What the finished NCT00042445 record still lists
NCT00042445 is an observational study that tracks outcomes without assigning an intervention. Its 1,456 participants enrollment target places it among the larger protocols in the corpus.
The record links to 0 conditions, and to 0 interventions.
NCT00042445 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00042445 about?
NCT00042445 is a clinical study titled "Brain Neoplasms, Leukemia and Petrochemical Exposures". The aim of this study is to examine the association of exposure to air contaminants (PAH \& VOC) emitted from the petrochemical industries, specific genetic polymorphisms (P4501A1 (MspI \& exon 7) and GSTM1 \& T1) of study subjects and their parents, and the risks of brain tumors and leukemia among ...
What is the current status of trial NCT00042445?
This trial is currently completed. The enrollment target is 1,456 participants. The study started on 2000-08. Estimated completion is 2005-07.
Who is sponsoring clinical trial NCT00042445?
This trial is sponsored by National Institute of Environmental Health Sciences (NIEHS), which has 145 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03936361 · 1,456 participants · Phase 3
Statins In Intracerbral Hemorrhage
- NCT06782347 · 1,454 participants · NA
Activating SilverSneakers Benefits for Seniors With Osteoarthritis
- NCT04566328 · 1,450 participants · Phase 3
Testing the Use of Combination Therapy in Adult Patients With Newly Diagnosed Multiple Myeloma, the EQUATE Trial
- NCT05229341 · 1,450 participants · NA
Evaluation of DNA Methylation Signatures for the Diagnosis and Management of Thyroid Nodules
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia